Related Experiment Videos
A method for the differential determination of plasma antithrombins
Journal of Clinical Pathology
|January 1, 1976
Summary
This study presents a new method to measure plasma antithrombins, specifically antithrombin III and alpha2 macroglobulin. Antithrombin III is the primary contributor to total antithrombin activity in healthy individuals.
Area of Science:
- Biochemistry
- Hematology
Background:
- Plasma contains multiple antithrombin proteins, including antithrombin III and alpha2 macroglobulin, which play crucial roles in regulating coagulation.
- Accurate measurement of individual antithrombin levels is essential for understanding hemostasis and diagnosing related disorders.
Purpose of the Study:
- To develop and validate a method for the differential determination of plasma antithrombin III and alpha2 macroglobulin.
- To assess the relative contribution of antithrombin III to total antithrombin activity in healthy subjects and patients with liver cirrhosis.
Main Methods:
- Selective inactivation of alpha2 macroglobulin using methylamine treatment.
- Quantification of thrombin inhibition by antithrombin III and alpha2 macroglobulin in defibrinated plasma.
- Pseudo-first order reaction kinetics were utilized for analysis.
Main Results:
- Antithrombin III constitutes approximately 70% of total antithrombin activity in healthy individuals.
- Patients with liver cirrhosis exhibit reduced total antithrombin activity.
- The relative contribution of antithrombin III is significantly lower in liver cirrhosis patients compared to healthy subjects.
Conclusions:
- The described method allows for the selective measurement of antithrombin III and alpha2 macroglobulin.
- Antithrombin III is the predominant antithrombin in healthy plasma.
- Altered antithrombin profiles, particularly a reduced role of antithrombin III, are observed in liver cirrhosis.